T3 N1 M0 rectal cancer: optimal initial management is total neoadjuvant therapy

被引：0
|
作者：
Nilsson, Per J. [1 ,2 ]
机构：
[1] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[2] Karolinska Inst, Dept Mol Med & Surg, Euegeniav 6, Hotellet pl 2, SE-17176 Stockholm, Sweden
来源：
BRITISH JOURNAL OF SURGERY | 2024年 / 111卷 / 01期
关键词：
PREOPERATIVE CHEMORADIOTHERAPY; OPEN-LABEL; CHEMOTHERAPY;
D O I：
10.1093/bjs/znad322
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [1] T3 N1 M0 rectal cancer: optimal initial management is upfront surgery
    Harris, Dean A.
    [J]. BRITISH JOURNAL OF SURGERY, 2024, 111 (01)
  • [2] T3 N1 M0 rectal cancer: the optimal initial management is long-course chemoradiotherapy
    Arthur, Claire
    Teo, Mark
    [J]. BRITISH JOURNAL OF SURGERY, 2024, 111 (01)
  • [3] T3N1M0 rectal cancer: the optimal initial management is systemic anti-cancer therapy
    Braun, Michael
    [J]. BRITISH JOURNAL OF SURGERY, 2024, 111 (01)
  • [4] Rectal cancer at the crossroads: The dilemma of clinically staged T3, N0,M0 disease
    Kachnic, Lisa A.
    Hong, Theodore S.
    Ryan, David P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) : 350 - 351
  • [5] THE ROLE OF ADJUVANT THERAPY AFTER RESECTION OF T1 N1 M0 AND T2 N1 M0 NON-SMALL CELL LUNG-CANCER
    FERGUSON, MK
    LITTLE, AG
    GOLOMB, HM
    HOFFMAN, PC
    DEMEESTER, TR
    BEVERIDGE, R
    SKINNER, DB
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1986, 91 (03): : 344 - 349
  • [6] Neoadjuvant Therapy for cT2N0M0 Rectal Cancer?
    Rubio, Gustavo A.
    Hurst, Roger D.
    Umanskiy, Konstantin
    Shogan, Benjamin D.
    Hyman, Neil
    Olortegui, Kinga Skowron
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 26 (02) : 479 - 482
  • [7] Neoadjuvant Therapy for cT2N0M0 Rectal Cancer?
    Gustavo A. Rubio
    Roger D. Hurst
    Konstantin Umanskiy
    Benjamin D. Shogan
    Neil Hyman
    Kinga Skowron Olortegui
    [J]. Journal of Gastrointestinal Surgery, 2022, 26 : 479 - 482
  • [8] Conservative surgery for T2>3 cm, T3 N0N1 M0 breast cancer after induction chemotherapy
    Bobin, JY
    Zinzindohoue, C
    Virelizier, CF
    Joulai, A
    Khaled, M
    [J]. BULLETIN DU CANCER, 2001, 88 (02) : 175 - 180
  • [9] A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer
    Stephens, RJ
    Girling, DJ
    Hopwood, P
    Thatcher, N
    [J]. LUNG CANCER, 2005, 49 (03) : 395 - 400
  • [10] TREATMENT OF MODIFIED STAGE-II (T1 N1 M0, T2 N1 M0) NON-SMALL CELL BRONCHOGENIC-CARCINOMA - A COMBINED MODALITY APPROACH
    NEWMAN, SB
    DEMEESTER, TR
    GOLOMB, HM
    HOFFMAN, PC
    LITTLE, AG
    RAGHAVAN, V
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1983, 86 (02): : 180 - 185
12345